The University of Southern California (USC) has announced a $40 million gift from the Alfred E. Mann Charities and Alfred E. Mann Foundation for Biomedical Engineering. 

The gift, which will expand USC’s partnership with the Children’s Hospital of Los Angeles (CHLA) and their joint biomedical research and innovation initiatives, marks the third and final distribution of a commitment from the renowned inventor, scientist, and engineer Alfred E. Mann, who died in 2016. USC and CHLA are collaborating to enhance healthcare research and innovation across the lifespan. Currently, the USC/CHLA Translational Cell Therapy Program consists of 40 principal investigators with more than $56 million in funding from the National Institutes of Health for cell and gene therapy research. Four initiatives have advanced to clinical testing or late pre-clinical development stages; six more are advancing toward clinical development.

“As we celebrate this new $40 million partnership with CHLA, we also pay tribute to the late Alfred E. Mann and his visionary donation,” said USC senior vice president for health affairs Steven Shapiro. “Together, we will continue to advance biomedical research and innovation initiatives that aim to improve child health.”

(USC Photo/Gus Ruelas)